SkinBioTherapeutics plc (AIM:SBTX)
London · Delayed Price · Currency is GBP · Price in GBX 6.35
+0.10 (1.60%)
Sep 25, 2026, 12:15 PM GMT
SkinBioTherapeutics Market Cap
SkinBioTherapeutics has a market cap or net worth of 16.2 million as of September 25, 2026. Its market cap has decreased by -61.77% in one year.
Market Cap
16.20M
Enterprise Value
14.01M
Revenue
5.23M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.35
ChartMarket Cap Chart
Since April 5, 2017, SkinBioTherapeutics's market cap has increased from 15.73M to 16.20M, an increase of 2.98%. That is a compound annual growth rate of 0.31%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 25, 2026 | 16.20M | -60.26% |
| Dec 31, 2025 | 40.76M | -3.56% |
| Dec 31, 2024 | 42.26M | 45.57% |
| Dec 29, 2023 | 29.03M | 8.17% |
| Dec 30, 2022 | 26.84M | -59.24% |
| Dec 31, 2021 | 65.85M | 79.74% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Apr 5, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Arecor Therapeutics | 33.41M |
| Hemogenyx Pharmaceuticals | 31.28M |
| ImmuPharma | 20.04M |
| IXICO | 16.42M |
| Oxford BioDynamics | 15.46M |
| Fusion Antibodies | 15.02M |
| Palatin Technologies | 12.90M |
| Aptamer Group | 11.23M |